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ABSTRACT 
International Journal of Exercise Science 8(3): 243-255, 2015. Caffeine enhances 
aerobic performance, but research is equivocal regarding anaerobic performance. This study 
examined effects of caffeine (7 mg/kg) on anaerobic performance in anaerobically active males (n 
= 10). Participants  completed counterbalanced, double blind caffeine (Caf) and placebo (Pl) trials 
including a) 6 x 15 s upper body Wingates (UWant), b) 6 x 15 s lower body Wingates (LWant) and c) 
6 x15 s maximal effort static hand grip test (HG) with 3 min recovery between bouts, 30 min 
between exercises. Peak power (Ppeak), mean power (Pmean), and heart rate (HR) as well as 
perceptual measures included ratings of perceived exertion (RPE), muscle pain perception (MPP), 
and perceived recovery status (PRS) were recorded per bout. Session RPE (S-RPE) (15 min post) 
for each exercise mode and trial RPE (T-RPE) [10 min post relative to testing period for each 
treatment (Caf vs. Pl)]. A series of 2 (trial) x 6 (bout) ANOVA’s assessed differences and Tukey’s 
LSD post hoc test were used when necessary. Results showed increased performance (main 
effect) (UWant) for Ppeak (Caf: 6.72 + 1.2 W/kg vs. Pl: 6.41 + 1.0 W/kg); and Pmean (Caf: 5.39 + 0.8 
W/kg vs. Pl: 5.18 + 0.8 W/kg); however no significant main effect for LWant or HG was observed.  
No significant differences were observed for perceptual measures. Caf improved anaerobic 
performance in repeated UWant (bouts 1-4) but not LWant or HG. Further studies are warranted to 
examine Caf ergogenic properties in repeated exercises dominated by anaerobic metabolic 
pathways given the equivocal results. 
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INTRODUCTION 
 
Caffeine (Caf) is a central nervous stimulant 
and a common constituent of supplements 
and energy-drinks based on the premise of 
improved physical performance with 
associated short term side effects including 
headache, nausea, and  tremors with mild 
consumption. However, long term caffeine 
use is not well understood.  The National 
Collegiate Athletic Association (31) 
mandates urinary levels > 15 µg/ml as 
illegal for competing athletes. This equates 
to 13 mg/kg or roughly 8 cups of coffee (12, 
17). Current literature has documented 
caffeine as an ergogenic aid in endurance 
exercise (For reviews see; Goldstein (14) 
and Magkos (29). However, a review by 
Davis (9) indicates that research 
investigating caffeine’s impact on anaerobic 
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performance has produced equivocal 
results, potentially attributable to testing of 
untrained individuals and habitual vs. non-
habitual caffeine users, diverse modes of 
testing (wingates vs. traditional weight 
lifting), muscle mass tested, and 
administration of varying caffeine dosages 
(2-10mg/kg).  
 
Lower body Wingate anaerobic tests (Want) 
are an accepted model to assess anaerobic 
capacity (23). However, the efficacy of 
caffeine on Want performance remains 
unclear. Greer (20) and Williams et al. (37) 
found caffeine (6-7 mg/kg of body mass) 
resulted in no change in repeated (20) or 
single effort (37) Wingates ranging from 15-
30 s. However, the authors attributed 
results to the untrained status of 
participants. Woolf et al (39) found caffeine 
(5 mg/kg) significantly increased total 
weight (reps x resistance) lifted for bench 
press and peak power for Wingate for 
highly fit males. However, total weight 
lifted for leg press only approached 
significance (p = 0.09). Anselm et al. (2) 
showed ingestion of 250 mg of caffeine 
prior to exercise increased peak anaerobic 
power in anaerobically untrained 
participants during a 6 s Want. Additionally, 
Kang et al. (26) found caffeine ingestion of 
both 2.5 and 5 mg/kg improved Want 
performance in untrained individuals. 
Conversely, Greer et al. (19) showed 
caffeine (6 mg/kg) had no ergogenic effect 
during repeated (4 x 30 s) Want with some 
evidence caffeine hindered performance in 
later bouts.  
 
Bugyi et al. (6) showed no significant 
difference in hand grip (HG) strength after 
caffeine ingestion of 167, 324, and 500 mg. 
However, caffeine dosage was not based on 
participant’s body mass and some 
participants likely failed to reach critical 
levels of caffeine ingestion (i.e. > 3-9 mg/kg 
of body mass) previously shown to elicit an 
increase in performance (17, 9). Further, 
with HG testing, the lack of mode specific 
trained participants could mitigate 
potential ergogenic properties of caffeine. 
Bellar et al. (5) observed a mild (not 
significant) difference in HG to time to 
failure (Caf: 104.98 + 57.95 s; Pl: 99.85 + 
78.39 s) with a concurrent significant 
reduction in subjective pain response (Caf: 
3.45 + 2.95, Pl: 4.84 + 2.92). It is inconclusive 
if the small volume of muscle involved in 
HG testing creates a paradigm less 
conducive to observing a performance-
enhancing effect from caffeine.  
 
Caffeine’s ergogenic properties were 
originally theorized due to enhanced free 
fatty acid mobilization consequent to 
glycogen sparing, however this provides 
minimal impetus for enhanced performance 
(with acute caffeine supplementation) 
during exercise dominated by oxygen-
independent metabolic pathways justifying 
further investigation. However, caffeine has 
been shown to have analgesic properties 
and a consistent blunting of perceptual pain 
responses in steady state exercise (27). Far 
less investigation into caffeine’s analgesic 
properties in repeated high intensity efforts 
has occurred. Caffeine buffers pain (vs. 
placebo), evidenced by perceptual and pain 
responses being blunted when similar work 
is completed or unaltered when greater 
work is performed (3, 18, 22, 34). 
Additionally, reduction in perceived levels 
of pain may be dose dependent per 
individual (32).While analgesic potential of 
caffeine offers a reasonable mechanism, 
discrepancies among previous studies 
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make further research warranted to clarify 
caffeine’s effect on anaerobic performance. 
Additionally, there appears to be a dose 
response effect with caffeine to potentially 
observe ergogenic benefits (3-7mg/kg). 
Therefore, this study examined effects of 
caffeine ingestion at 7mg/kg on repeated 
upper and lower body Want and hand grip 
performance in anaerobically trained males.   
 
METHODS 
 
Participants 
Participants were males (ages 19-45) who 
frequently engaged in high-intensity 
training (HIT) methods involving both 
upper and lower body exercises >3 
days/week. Participants completed an 
informed consent form and were screened 
for apparent chronic disease risks using the 
PAR-Q (38) and a health questionnaire.  
Participants also completed questionnaires 
concerning daily caffeine use (33) and 
training history. Height (cm) and body 
mass (kg) were determined using a 
stadiometer (Detecto, Webb City, MO) and 
a calibrated digital scale (Tanita BWB-800, 
Tokyo, Japan). Body fat percentage was 
estimated using skinfold calipers (Lange, 
Cambridge, MD) and the three site method 
for males (chest, abdomen, thigh) (24). 
During each trial, peak heart rate was 
obtained using Team2 system heart rate 
monitors (Polar Electro Oy, Kempelee, 
Finland).   Participants were instructed to 
report to the lab for testing well-hydrated, 
having avoided consumption of caffeine, 
alcohol, and any heavy physical exertion 24 
h prior to all trials. Participants 
documented their dietary intake 24 h prior 
to the first session which served as a 
familiarization trial and were instructed to 
duplicate the diet for each trial.  
Participants followed these instructions and 
replicated dietary intake for all subsequent 
trials. Descriptions of exercise testing are 
included below and were replicated for the 
familiarization session and both treatment 
sessions. All procedures were approved by 
the institutions internal review board (IRB) 
and in followed procedures in accordance 
with the ethical standards of the Helsinki 
Declaration.  
 
Table 1. Descriptive characteristics for participants 
(n = 10). 
Variable Mean SD 
Age (yrs) 23.9 5.4 
Height (cm) 179 6 
Body mass (kg) 86.0 10.4 
BMI 26.8 2.3 
Body Fat (%) 10.9 2.4 
Daily caffeine use (mg/day) 189.0 119.7 
Daily caffeine use (mg/kg) 2.21 1.3 
 
Protocol 
Participants completed a 5 min upper body 
cycle specific warm-up on an ergometer 
(Ergomedic 828E, Monark Inc., Varberg, 
Sweden) equipped with handgrips and 
mounted on a table designed for arm 
ergometry. Participants completed 6 x 15 s 
upper body Want (UWant). Resistance was 
individualized at a ratio of 0.062 kp/kg of 
body mass (23) and the weight basket was 
automatically dropped upon reaching 
120rev/min. Each bout was separated by 3 
min of passive recovery. Peak power (Ppeak), 
mean power (Pmean), and fatigue percentage 
(Ftg%) were collected. Subjective data 
included rating of perceived exertion (RPE) 
for each bout 1 min into recovery. Session 
(S-RPE) was collected 15 min after 
completion of the last UWant using the 
Omni Pictorial 0-10 scale (36). The 
Perceived Recovery Scale (PRS) (28) was 
used to assess participant’s subjective 
feelings of readiness 15 s prior to the start 
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of each Want on a 10cm visual analog scale 
Muscle-pain perception (MPP) was 
assessed using a previously validated scale 
(8). MPP was assessed after 2 min recovery 
following each 15 s Wingate on a 10cm 
visual analog scale. Upon completion of the 
UWant, participants arm cycled (20-30 
rev/min with no resistance) as an active 
“cool-down” period for 5 min. 
 
Participants recovered in a seated position 
for 30 min upon the completion of the last 
UWant before the lower body Want (LWant). 
LWant were conducted in the exact manner 
as UWant Participants completed a 5 min 
warm-up at a standardized 50-60 rev/min 
(with no resistance) on a cycle ergometer 
(Ergomedic 894E, Monark Inc., Varberg, 
Sweden). Participants completed 6 sets of 
15 s LWant. Resistance was a ratio of 0.087 
kp/kg of body mass (23) and the weight 
basket was automatically dropped upon 
reaching 120rev/min. Upon completion of 
the last LWant, participants cycled 5 min at 
30-40 rev•min-1 with no resistance as an 
active “cool-down”. 
 
Participants completed 6 x 15 s maximal 
effort hand grip strength tests (HG) with 
each hand (Baseline Hydraulic Hand 
Dynamometer, Fabrication Enterprises Inc., 
Irvington, NY) after completion U and L 
Want. Participants completed the trials in a 
standing position, arms at sides, and 
dominant hand first. Each bout was 
separated by 3 min passive recovery. Peak 
and minimum power, RPE, MPP, PRS, and 
S-RPE were recorded in the same manner 
as with Wingate testing. Trial (T-RPE) was 
collected 20 min after completion of trial 
(Caf and Pl) using the Omni Pictorial 0-10 
scale (36). 
 
Participants ingested either caffeine (Caf) (7 
mg/kg) or matched placebo (Pl) pills 
(lactose) in soft capsule form, 1 h prior to 
reporting to the laboratory. The primary 
investigator prepared paired sets of pills 
(Caf and Pl) in clear storage bags and 
received verbal confirmation of ingestion 1 
hr prior to trial by the participant. Caf and 
Pl trials were completed in a 
counterbalanced order and in a double-
blind manner. 
 
Statistical Analysis 
Data was analyzed utilizing SPSS and an 
alpha of 0.05 was set a priori. A series of 2 
(trial) x 6 (Wingate) repeated measures 
ANOVA’s were used to compare 
dependent measures including 
performance (Ppeak, Pmean, Ftg%)  and 
perceptual data (MMP, RPE, and PRS). A 
two-way repeated-measures ANOVA and 
Tukey’s LSD post hoc test were used to 
examine differences in HR. Session RPE 
and Trial RPE were analyzed between Caf 
and Pl trials using paired samples T-test per 
exercise mode. 
 
RESULTS 
 
Descriptive data are shown in Table 1. Trial 
means for performance are shown in Table 
2. Upper Body Wingate:  A significant main 
effect for trial was observed for Ppeak 
(Figure 1) and Pmean (Figure 2). Follow up 
tests showed significantly greater values for 
CA for Ppeak on bouts 1 and 2 (Figure 1) and 
for Pmean for bouts 1, 2 and 4 (Figure 2). No 
significant difference was observed for HR 
(b/min) (Caf: 158 + 16 vs. Pl: 158 + 10). No 
Significant differences were found for Ftg% 
(Caf: 60.5 + 1.4 %vs. Pl: 60.5 + 3.5 %), RPE, 
MPP, PRS, S-RPE. No significant difference 
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was found in T-RPE (Caf: 6.2 + 0.8 vs. Pl: 5.9 
+ 1.4). 
 
 
Figure 1. Caf vs. Pl UWant Ppeak. *Caf significantly 
higher than Pl per bout. Caf significantly higher 
than Pl, p = 0.04 (main effect).   
 
 
Figure 2. Caf vs. Pl LWant Ppeak. * Pl significantly 
higher than Caf p = 0.04. 
 
Follow up tests showed significantly 
greater values for Pl for PRS on bouts 4, 5, 
and 6. No significant difference was 
observed for mean LWant Ppeak (Figure 3). A 
significant main effect was observed for 
Pmean (Figure 4). Follow up tests showed 
significantly greater values for Pl for Pmean 
on bout 6 (Figure 4).HR was significantly 
different for LWant (Caf: 163 + 7 b/min vs. 
Pl: 158 + 8 b/min) and follow up tests 
showed significantly greater values for Caf 
for HR on bouts 2, 3, 4, 5, and 6. 
Additionally, LWant PRS was significantly 
higher for Pl (Table 2) No significant 
differences were observed for LWant Ftg% 
(Caf: 59.2 + 2.9 % vs. Pl: 59.2 + 4.0 %), RPE, 
MPP, or S-RPE (Table 2). 
 
Figure 3. Caf vs. Pl UWant Pmean. *Caf significantly 
higher than Pl. Caf significantly higher than Pl, p = 
0.009 (main effect). 
 
 
Figure 4. Caf vs. Pl LWant Pmean. *Pl significantly 
higher than Caf. Pl significantly higher than Caf, p = 
0.03 (main effect). 
 
No significant differences were found 
between trials for HG peak power (Caf: 52.7 
+ 1.7 kg vs. Pl: 53.0 + 1.3 kg), RPE, MPP, or 
PRS. HG HR (b/min) was found 
significantly higher (Caf: 130 + 15, vs. Pl: 
122 + 16) and follow up tests showed 
significantly greater values for Caf for HR 
for all bouts  No significant difference was 
found in HG S-RPE (Table 2). 
 
DISCUSSION 
 
The major finding of the current study was 
7 mg/kg of Caf resulted in a significant  
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Table 2. Perceptual data for Caf vs. Pl. Means and 
standard deviations. 
increase in Ppeak and Pmean in UWant Caf, 
while no significant difference was 
observed in Ppeak in LWant and HG 
performance. However, Caf resulted in a 
significantly greater Pmean in LWant . 
Further, RPE for UWant was not 
significantly different but group means 
were higher for Caf vs. Pl (Table 2) 
corresponding with higher Ppeak following 
caffeine ingestion indicating subjective 
feelings reflected  increased work. Caf vs. Pl 
RPE in UWant 4 was not significant (Caf: 5.8 
+ 1.3, Pl: 5.4 + 0.8) (p = 0.16).  Caf vs. Pl 
UWant S-RPE was not significantly different 
(Caf: 6.1 + 1.4, Pl: 5.98+ 1.1), although 
performance was greater following Caf 
ingestion. Collectively, perceptual 
responses considered concurrent with 
performance between trials suggests 
caffeine may blunt perceived exertion and 
pain response allowing for increased 
volume of work. 
 
Currently there is limited data on caffeine’s 
ergogenic potential in upper body 
ergometry. Recent investigation by Aedma 
et al (1) impact of caffeine supplementation 
(5mg/kg) utilizing repeated upper body 
ergometry efforts (4 x 6 min, 30 min 
recovery) in attempt simulate match day for 
wrestlers. Caffeine negatively impacted 
performance in upper body ergometry (p= 
0.05) but not in the placebo trial. 
Conversely, we found caffeine improved 
performance in upper body ergometry. 
However, this could be attributed to the 
shorter duration (15 s vs. 6 min) of exercise 
bouts in the current study. Beck et al. (4) 
examined acute caffeine supplementation 
on trained individuals between multiple 
muscle groups in traditional weight lifting 
exercises (leg extension and bench press) 
and repeated (2) Want, observing improved 
performance for upper body, but not lower 
body. Green et al. (18) found caffeine 
significantly increased reps to failure 
during leg press in the third (but not first 
two) of three sets, but in none of three sets 
for bench press. Hudson et al. (22) tested 
trained individuals on upper body (arm 
curls) and lower body (leg extensions) 
resistance exercise. Leg extension and arm 
curl reps to failure significantly improved 
(attributed to first two of four sets to 
failure). Current results were similar to 
Beck et al. (4) in that caffeine’s ergogenic 
properties were limited to upper body 
exercise and not lower body. Hudson et al. 
(22) also observed improved performance 
for upper body exercise that was limited to 
the first two sets (and not the later sets). 
However, Green et al. (18) contradict the 
current study, where significant 
improvement was observed in the early sets 
(1st and 2nd), but not in the later UWant 
possibly because the intense fatigue- 
inducing nature of UWant. Additionally, 
mean RPE for UWant approached 
significance (p = 0.16) systematically 
increasing with the increased volume of 
work performed. Though no significant 
difference was observed for UWant Caf vs. 
Variable Caffeine Placebo p value 
UWant  RPE mean 5.5 + 1.6       5.2 + 1.3 0.16 
LWant  RPE mean 6.1 + 1.6       5.8 + 1.5 0.11 
HG RPE mean 3.3 + 1.5 2.7 + 1.2 0.41 
UWant PRS 5.3 + 2.2 5.7 + 1.8 0.23 
LWant PRS 5.0 + 2.2 5.7 + 1.9 0.02 
HG PRS 7.1 + 1.9 7.6 + 1.3 0.17 
UWant MPP 4.1 + 2.4 3.9 + 1.8 0.43 
LWant MPP 4.8 + 1.8 4.2 + 2.2 0.13 
HG MPP 2.3 + 1.5 2.0 + 1.4 0.21 
UWant S-RPE 6.1 + 1.4 5.8 + 1.1 0.09 
LWant S-RPE 7.0 + 0.9 6.4 + 1.5 0.20 
HG S-RPE 3.4 + 1.5 3.4 + 1.7 0.50 
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Pl, similar peak HR responses (158 + 16 
b/min vs. 158 + 11 b/min) with greater 
power output during Caf may offer 
evidence of caffeine’s ergogenic properties.  
 
The equivocal nature of the literature 
regarding upper vs. lower body 
performance and caffeine is difficult to 
explain; however, muscle volume recruited 
may be a key factor. Svenningsson et al. 
(35) found increased motor unit activity in 
rats via antagonism of adenosine receptors 
at doses of caffeine of 7.5 mg/kg. Assuming 
greater muscle volume contains a greater 
absolute volume of adenosine receptors, it 
is plausible that individuals with a higher 
overall volume of muscle mass may 
potentially respond more positively to 
caffeine supplementation, although direct 
evidence is lacking. Given the “trained” (vs. 
sedentary) status of current participants, 
the expectation for improved performance 
would be plausible based on the previous 
statement. However, various performance 
tasks may differ following acute caffeine 
supplementation based on muscle volume 
involved in testing which is often dictated 
by testing mode. The results of the current 
study potentially support the previously 
stated theory given the improved 
performance for upper body, similar to 
Beck et al. (4), but not lower body, 
contradicting the results of Green et al. (18) 
and Hudson et al. (22) (see figure 1, 2, 3). 
Though the results of the studies are 
contradictory regarding muscle body 
regions that experienced performance 
differences; all three studies utilized trained 
individuals and observed a positive effect 
from caffeine in at least one body region. 
 
Greater absolute adenosine receptor 
volume would be anticipated with greater 
muscle volume. However, it is also 
reasonable that highly trained individuals 
may also be more likely to experience 
improvement if caffeine’s ergogenic benefit 
is rooted in adenosine receptor antagonism. 
Because untrained muscle lacks neural 
adaptation (vs. trained muscle), a lower 
percentage and absolute number of total 
fibers may be activated during work. 
Consequently, there is less opportunity an 
ergogenic benefit to manifest through 
adenosine receptor antagonism. This theory 
has not been directly investigated yet could 
partially explain observations of 
improvement in trained and not in 
untrained participants.  Further 
investigation is needed to clarify the 
potential role of muscle volume and 
training status with regard to caffeine, in 
particular, mechanistic factors. 
 
Current results for LWant support Collomp 
et al. (7), Williams et al. (37), and Greer et 
al. (19) that Caf had no effect on LWant 
performance. Williams et al. (37) observed 
caffeine having no effect on mean power in 
15 s maximal effort cycling. Greer et al. (19) 
utilized a similar Caf does (6 mg/kg) and 
found peak and mean performance did not 
improve on the first 3 of 4 consecutive 
LWant but did increase on the final bout. 
However, it is important to note the 
participants in Greer et al (19) were 
unaccustomed to intense exercise. Plausibly 
no effect was observed because the 
utilization of untrained individuals 
prevented potential benefits from caffeine 
supplementation. Similarly, testing of non-
habitual users creates the potential for 
caffeine-induced nausea which may impair 
performance at 6 mg/kg of caffeine (21). 
However the current study included 
trained individuals while finding a 
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significant difference between Pl vs. Caf 
Pmean LWant (Figure 4). Additionally, RPE in 
the 6th Want was significantly higher (p = 
0.02, Caf: 7.6 + 0.8 vs. Pl: 6.9 + 1.0).  
Astorino et al. (3) found similar RPE and 
pain levels during leg extensions (2 sets of 
40) Caf (5mg/kg) vs. Pl demonstrating a 
lack of pain blunting effect of caffeine on 
RPE similar to the current study. It is 
unclear why RPE was higher given the lack 
of differences in performance in the current 
study. LWant always followed UWant bouts 
and significantly greater performance was 
observed for Caf trials during UWant (Figure 
2). While remote, it is possible that, because 
LWant followed the upper body bouts, RPE 
was higher during Caf because of greater 
“pre” fatigue resulting from greater work 
volume during Caf UWant (Table 2). 
Interesting to note, LWant PRS was 
significantly higher for Pl vs. Caf (5.68 + 1.9 
vs. 5.00 + 2.2). Greater PRS demonstrated 
participant’s subjective feelings of greater 
recovery and preparedness for ensuing 
bouts during Pl. This potentially supports 
the concept that lack of a significant 
difference for LWant may be attributed to 
residual fatigue from UWant. A negative 
reaction to high caffeine dosage can 
arguably be eliminated as no adverse 
reactions were observed or reported by 
participants. 
 
Similar to Bugyi et al. (6), the current study 
showed no significant difference in mean 
hand grip performance between Caf vs. Pl 
trials. However, unlike the current study, 
caffeine dosage was not based on 
participant’s body mass in Bugyi et al. (6). 
Basing dosage on participant body mass 
plausibly ensured that critical levels of 
caffeine to induce potential ergogenic 
effects were reached in those who would 
respond positively to caffeine 
administration. Our mode (repeated 
maximal static efforts) could negate any 
potential ergogenic response given the 
small volume of muscle utilized during 
hand grip testing. If a critical level of 
muscle volume is necessary to observe an 
ergogenic effect from caffeine, detection of 
improved performance would be difficult 
in the current (handgrip testing) paradigm. 
No analgesic effect of caffeine was observed 
in HG MPP (Table 2) in the current study 
contradicting Bellar et al. (5) who found 
pain perception was lowered by caffeine in 
hand grip to exhaustion Caf even when 
group means for time to exhaustion were 
higher Caf. However, the contradiction in 
perceptual ratings potentially could be 
attributed to mode of testing (15 s vs. time 
to exhaustion). Greater exercise duration 
(~100 s vs. a standardized 15 s) would have 
the potential to generate greater pain levels 
creating a situation in which caffeine, as an 
analgesic, might have greater potential to 
function. Lack of differences in HG MPP, 
with similar power, supports the notion 
that pain perception is influenced by 
volume of muscle performing work (i.e. 
relationship between muscle volume and 
volume of work performed influence on 
pain perception) and in this paradigm 
caffeine failed to influence MPP. 
 
During high intensity exercise, caffeine has 
demonstrated analgesic properties and 
consistent blunting effect on perceptual 
responses (10, 30). Although no difference 
was observed in power levels, RPE 
approached significance during Pl LWant (p 
= 0.11), failing to provide strong support for 
caffeine’s hypoalgesic effects of a lower 
RPE at the same workload (Caf: 3.42 + 1.50 
vs. Pl: 3.27 + 1.71). It is plausible that 
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caffeine buffers pain as similar or increased 
work is performed (caffeine vs. placebo 
trials); yet perceptual responses are blunted 
or unaltered respectively (3, 18, 22, 34). 
Furthermore, current results show 
perceptual pain measures systematically 
increased with increased muscle volume 
utilized (Table 2). Additionally, reduction 
in reported levels of pain may be dose 
dependent due to individual variability 
required to reach critical levels (32). Killen 
et al. (27) observed significantly lower 
Session-RPE for Caf vs. Pl (6.1 ± 2.2 vs. 6.8 ± 
2.1) following 30 min of sub-max cycling 
equated for intensity and total work 
volume. In the current study, S-RPE was 
not significantly different for any exercise, 
nor was T-RPE significantly different for 
Caf. However, group means were higher 
for all 3 exercises Caf vs. Pl RPE (Table 2). 
The contradictory results between studies 
may potentially be explained by mode of 
exercise (aerobic vs. anaerobic). As stated 
earlier, LWant PRS was significantly higher 
for Pl (vs. Caf), but no significant difference 
was observed for PRS in UWant or HG; 
however, group means were higher for all 
exercises during Pl (Table 2). This indicates 
the high caffeine dosage may have 
impacted some participants negatively 
given the subjective measures show 
participants anticipated performing better 
on the ensuing bout (when not on caffeine). 
Laurent et al. (28) demonstrated a 
correlation between expected performance 
using the PRS scale and actual performance 
for the ensuing exercise bout.  In that study 
recovery (PRS) was estimated prior to an 
entire exercise bout following variable days 
of recovery. In the current study, PRS was 
taken repeatedly between bouts essentially 
reflecting participant’s perceived readiness 
for the next bout. Results were inconclusive 
given participants performed better during 
the UWant Caf trial but PRS group means 
were higher during Pl; LWant Pmean was 
higher during Pl and correlated with a 
higher PRS, while HG max performance 
was not statistically different nor was PRS 
(though group mean was higher during Pl). 
PRS responses and performance in the 
current study was potentially disrupted by 
the acute caffeine supplementation and the 
way in which the PRS scaled was applied. 
The PRS scale was intended to assess 
recovery status prior to exercise in a global 
manner and has not been validated to 
function as a readiness scale between acute 
repeated bouts. Even so, it is conceivable 
that the subjective scale (PRS) lacked 
sensitivity to detect the small differences in 
performance in the current design.  Further 
investigation is needed to determine how 
caffeine ingestion may alter perceptual 
feelings regarding recovery status. 
 
Because there appears to be inter-individual 
variability regarding caffeine’s’ ergogenic 
potential, conclusions based solely on 
analysis of mean data may be misleading. It 
is therefore important to consider 
individual responses. In the current study 
7/10 individuals consumed caffeine daily 
at rates > 1.8mg/kg. Of these 7 habitual 
users, 6 showed mean improvement 
following Caf (vs Pl) ingestion for Peak for 
UWant (0.61W/kg) and LWant 0.44 W/kg), 
while the single non-responder (Pl > Caf 
performance) possessed the highest BF % in 
the study and produced the lowest W/kg 
UWant, Pmean and LWant, Pmean in the current 
study (supporting earlier speculation based 
on Svenningsson et al. (35)). Although, 
aggregate data show no significant 
difference in LWant  Ppeak, individual 
responders to acute caffeine 
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supplementation improved LWant Ppeak 
between 0.22-1.34 W/kg (~ 21-131 Watts). 
Additionally, the responders improved 
UWant, Ppeak (0.34-1.04 W/kg) or (~ 33-102 
Watts). Comparatively the 3 designated 
non-responders demonstrated average 
valued reflecting impaired performance for 
UWant, Ppeak (-0.07 W/kg or -6.65 Watts) and 
LWant, Ppeak (-0.14 W/kg or -13.3 Watts) Caf 
vs. Pl. Woolf et al. (39) tested collegiate 
football players after ingestion of 5 mg/kg 
on 40-yard sprint, 20-yard shuttle test, and 
bench press reps to failure, showing no 
significant difference between placebo and 
caffeine trials when comparing group 
means. However, 59% of participants 
improved 40-yard sprint time; 59% 
improved 20-yard shuttle time, and 47% 
improved bench press reps to failure. 
Similar to current results, Woolf’s study 
emphasizes that it is imperative to examine 
‘responders vs. non-responders’ (i.e. 
individual data) to provide an in-depth 
evaluation regarding effects of caffeine on 
anaerobic exercise. Similarly, Jordan et al. 
(25) examined acute caffeine 
supplementation at 6 mg/kg on repeated 
sprints (12 x 30 m) between caffeine naïve 
(<50 mg per day) and habitual (>300 mg 
per day) college age males and females. No 
significant differences were found between 
Caf consumers and non-consumers in 
performance. However fastest individual 
sprint time for all participants followed 
caffeine consumption. Additionally, mean 
sprint times for the caffeine trial were faster 
compared to mean sprint times for the 
placebo trial and mean RPE was higher 
during the caffeine trial compared to the 
placebo trial (13.9 + 1.5 vs. 13.3 + 1.6). While 
significant differences in sprint times were 
not identified based on common values 
used to restrict type I error rate, it is 
emphasized that seemingly minor 
differences in anaerobic athletic 
competitions can be of great practical 
importance. 
 
More research is required to definitively 
determine the effect of caffeine on intense 
anaerobic exercise. One flaw of acute 
caffeine supplementation research is a clear 
consensus on what constitutes a habitual 
caffeine user.. Future studies should define 
habitual users using daily intake relative to 
body mass (mg/kg) rather than daily 
absolute caffeine ingestion. Caffeine should 
be administered during a multitude of 
activities in dosages at or above levels 
previously shown to enhance performance. 
The ability to mask caffeine 
supplementation is difficult, but 6 out of 10 
participants incorrectly guessed which 
treatment they received first and was 
considered but a direct analysis was 
omitted. However, one constant that should 
remain is the utilization of anaerobically 
trained individuals. In Davis’ (9) review, of 
18 studies showing an ergogenic effect of 
caffeine, 15 utilized trained individuals, 2 
untrained and 1 did not provide training 
background. Further investigations should 
focus on more practical approaches 
reflecting athletic competitions and 
training, utilizing a strength-to-weight 
ratio. It is also critical to assess individual 
responses rather than drawing conclusions 
based solely on analysis of aggregate data. 
  
The current study demonstrated caffeine’s 
ergogenic properties in certain paradigms 
(upper body wingates during early sets) 
and failure to influence performance in 
others (lower body wingates and static 
hand grips). Plausibly, caffeine’s ergogenic 
properties may be limited to trained 
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individuals targeting appropriate muscle 
mass (mode and set dependent) following 
ingestion of a required critical dosage. 
Given a large dose of caffeine, acute 
negative side effects are plausible which 
could hinder performance. Additionally, 
research should not focus only on 
performance variables; instead continue to 
investigate perceptual responses to caffeine 
during exercise. Admittedly, one 
confounder of caffeine research is the 
dynamic variability in methodology 
making it problematic to compare findings 
to identify a definitive, global answer 
regarding caffeine’s potential impact on 
exercise bouts dominated by anaerobic 
metabolic ATP production.  Therefore 
research should continue to focus on the 
responder vs. non-responder concept in 
attempts to identify the parameters that 
create a responder to caffeine’s ergogenic 
properties. 
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